| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.98e-05 | 21 | 157 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | calcium ion binding | FLG HSPG2 PCDHGC5 PCDHGB7 PCDHGB3 CDHR3 FAT3 CAPN1 RYR3 CAPN13 SCUBE1 FAT2 SCUBE2 CELSR2 RPTN PCDHGC3 PROS1 | 8.75e-05 | 749 | 157 | 17 | GO:0005509 |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA2D1 PDE4B MYOT ATP8A2 TMOD4 ITGA2 RYR3 JUP KCNMA1 TMOD1 PLA2G6 TBX20 NOS1 UTY SCN3B | 3.99e-07 | 400 | 156 | 15 | GO:0006936 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | MYOT PCDHGC5 PCDHGB7 PCDHGB3 CDHR3 FAT3 FAT2 CELSR2 PKD1 PCDHGC3 | 1.65e-06 | 187 | 156 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | protein tetramerization | 2.34e-06 | 113 | 156 | 8 | GO:0051262 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA2D1 PDE4B MYOT ATP8A2 TMOD4 ITGA2 ECE1 RYR3 JUP KCNMA1 TMOD1 PLA2G6 TBX20 NOS1 UTY SCN3B | 4.17e-06 | 547 | 156 | 16 | GO:0003012 |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 7.24e-06 | 36 | 156 | 5 | GO:0010560 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 8.87e-06 | 18 | 156 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.12e-05 | 19 | 156 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 1.23e-05 | 40 | 156 | 5 | GO:1903020 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.19e-05 | 153 | 156 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 2.49e-05 | 23 | 156 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 2.59e-05 | 77 | 156 | 6 | GO:0051289 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 2.97e-05 | 24 | 156 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | BOC HSPG2 FLNB WASL MYOT MYO9B ATP8A2 CDHR3 FAT3 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 MAP3K1 WDR47 POSTN NRXN3 CELSR2 CAPRIN2 BAMBI VASP | 3.33e-05 | 1194 | 156 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | Golgi localization | 4.82e-05 | 27 | 156 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | BOC HSPG2 WASL MYOT MYO9B ATP8A2 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 POSTN NRXN3 CELSR2 CAPRIN2 VASP | 4.93e-05 | 819 | 156 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.18e-05 | 127 | 156 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | BOC HSPG2 WASL MYOT ATP8A2 FAT3 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 NRXN3 CELSR2 CAPRIN2 VASP | 5.36e-05 | 748 | 156 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | BOC HSPG2 WASL MYOT MYO9B ATP8A2 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 POSTN NRXN3 CELSR2 CAPRIN2 VASP | 5.49e-05 | 826 | 156 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 5.60e-05 | 28 | 156 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 5.60e-05 | 28 | 156 | 4 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 5.60e-05 | 28 | 156 | 4 | GO:0048313 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 7.53e-05 | 93 | 156 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.22e-04 | 34 | 156 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | BOC HSPG2 WASL MYOT ATP8A2 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 POSTN NRXN3 CELSR2 CAPRIN2 VASP | 1.25e-04 | 802 | 156 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MYOT PCDHGC5 PCDHGB7 PCDHGB3 CDHR3 FAT3 FAT2 CELSR2 PKD1 PCDHGC3 | 1.40e-04 | 313 | 156 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 1.71e-04 | 37 | 156 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 1.77e-04 | 69 | 156 | 5 | GO:0010559 | |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 FLNB CACNA2D1 WASL PDE4B MYO9B FRMD7 CAPN1 ESPNL TMOD4 MAP3K1 NEDD9 JUP TMOD1 NOS1 UTY VASP SCN3B | 1.90e-04 | 912 | 156 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 2.03e-04 | 158 | 156 | 7 | GO:0030177 | |
| GeneOntologyBiologicalProcess | protein polymerization | WASL CAPN1 GOLGA6C GOLGA6D TMOD4 GOLGA6B GOLGA6A MAP3K1 TMOD1 VASP | 2.36e-04 | 334 | 156 | 10 | GO:0051258 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.52e-04 | 217 | 156 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 2.82e-04 | 42 | 156 | 4 | GO:0010765 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 3.19e-04 | 121 | 156 | 6 | GO:0090263 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine catabolic process | 3.38e-04 | 4 | 156 | 2 | GO:0046338 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 3.53e-04 | 80 | 156 | 5 | GO:1903018 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.64e-04 | 124 | 156 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | axonogenesis | BOC HSPG2 MYOT ATP8A2 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 NRXN3 VASP | 3.80e-04 | 566 | 156 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | BOC HSPG2 MYOT ATP8A2 LRTM1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A ECE1 WDR47 NRXN3 BHLHA15 VASP | 3.81e-04 | 642 | 156 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell junction organization | WASL MYOT PCDHGC5 CDHR3 LRTM1 GRID1 GRIN2B ITGA2 CSMD2 ITGAV NEDD9 JUP NRXN3 BHLHA15 CAPRIN2 DLG2 TNS1 PCDHGC3 | 4.21e-04 | 974 | 156 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 4.33e-04 | 296 | 156 | 9 | GO:0051259 | |
| GeneOntologyBiologicalProcess | endoderm formation | 5.12e-04 | 49 | 156 | 4 | GO:0001706 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 5.88e-04 | 22 | 156 | 3 | GO:1902514 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transmembrane transport | 5.88e-04 | 22 | 156 | 3 | GO:1902307 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 5.98e-04 | 247 | 156 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 6.73e-04 | 23 | 156 | 3 | GO:0061577 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 7.66e-04 | 197 | 156 | 7 | GO:1902904 | |
| GeneOntologyCellularComponent | Z disc | 1.90e-05 | 151 | 157 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 1.94e-05 | 249 | 157 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | I band | 3.74e-05 | 166 | 157 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 4.25e-05 | 273 | 157 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.05e-05 | 290 | 157 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.06e-04 | 33 | 157 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.06e-04 | 33 | 157 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | supramolecular fiber | TLK2 COL5A2 DLGAP2 FLNB PDE4B MYOT DCDC1 MYO9B GOLGA6C GOLGA6D TMOD4 GOLGA6B GOLGA6A GRIN2B MAP3K1 RYR3 WDR47 JUP TMOD1 NOS1 SCN3B | 2.05e-04 | 1179 | 157 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TLK2 COL5A2 DLGAP2 FLNB PDE4B MYOT DCDC1 MYO9B GOLGA6C GOLGA6D TMOD4 GOLGA6B GOLGA6A GRIN2B MAP3K1 RYR3 WDR47 JUP TMOD1 NOS1 SCN3B | 2.24e-04 | 1187 | 157 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | Golgi membrane | WASL ATP8A2 MGAT4A KIAA0319L GOLGA6C GOLGA6D GOLGA6B GOLGA6A ST6GALNAC2 GALNT13 ZDHHC9 PKD1 DSEL SEC23A PROS1 | 3.60e-04 | 721 | 157 | 15 | GO:0000139 |
| GeneOntologyCellularComponent | spindle pole | 9.29e-04 | 205 | 157 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.46e-03 | 110 | 157 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | cornified envelope | 1.81e-03 | 69 | 157 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TLK2 PDE4B MYO9B GOLGA6C GOLGA6D GOLGA6B GOLGA6A ITGA2 ECE1 RYR3 EPG5 SLC2A10 KLHL7 KCNMA1 NOS1 SEC23A | 1.81e-03 | 934 | 157 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | cation channel complex | 2.03e-03 | 235 | 157 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BOC CNTNAP3B DLGAP2 FLNB PDE4B MYOT FAT3 FRMD7 CNTNAP3 GOLGA6C GOLGA6D GOLGA6B GOLGA6A GRIN2B WDR47 USP8 KCNMA1 DLG2 NOS1 | 2.20e-03 | 1228 | 157 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | calcium channel complex | 2.23e-03 | 73 | 157 | 4 | GO:0034704 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 2.04e-06 | 24 | 126 | 5 | MP:0031355 | |
| MousePheno | increased alveolar macrophage number | 5.87e-06 | 14 | 126 | 4 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 7.95e-06 | 15 | 126 | 4 | MP:0014227 | |
| MousePheno | absent acrosome | 9.10e-06 | 32 | 126 | 5 | MP:0008839 | |
| MousePheno | pancreas fibrosis | 3.87e-05 | 8 | 126 | 3 | MP:0003334 | |
| MousePheno | abnormal Golgi vesicle transport | 4.06e-05 | 22 | 126 | 4 | MP:0030949 | |
| MousePheno | abnormal alveolar macrophage morphology | 9.40e-05 | 27 | 126 | 4 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 1.09e-04 | 28 | 126 | 4 | MP:0009833 | |
| MousePheno | abnormal hepatocyte morphology | 1.28e-04 | 166 | 126 | 8 | MP:0000607 | |
| Domain | LAM_G_DOMAIN | 2.08e-11 | 38 | 156 | 9 | PS50025 | |
| Domain | Laminin_G_2 | 3.44e-11 | 40 | 156 | 9 | PF02210 | |
| Domain | LamG | 8.66e-11 | 44 | 156 | 9 | SM00282 | |
| Domain | Laminin_G | 1.18e-09 | 58 | 156 | 9 | IPR001791 | |
| Domain | - | 1.00e-07 | 95 | 156 | 9 | 2.60.120.200 | |
| Domain | ConA-like_dom | CNTNAP3B HSPG2 FAT3 CNTNAP3 LAMA4 RYR3 FAT2 NRXN3 CELSR2 ADGRD1 PROS1 | 2.36e-06 | 219 | 156 | 11 | IPR013320 |
| Domain | EGF | CNTNAP3B HSPG2 FAT3 CNTNAP3 LAMA4 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 4.65e-06 | 235 | 156 | 11 | SM00181 |
| Domain | CADHERIN_1 | 4.82e-06 | 113 | 156 | 8 | PS00232 | |
| Domain | Cadherin | 4.82e-06 | 113 | 156 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 5.15e-06 | 114 | 156 | 8 | PS50268 | |
| Domain | - | 5.15e-06 | 114 | 156 | 8 | 2.60.40.60 | |
| Domain | CA | 5.50e-06 | 115 | 156 | 8 | SM00112 | |
| Domain | Cadherin-like | 5.86e-06 | 116 | 156 | 8 | IPR015919 | |
| Domain | Cadherin | 6.66e-06 | 118 | 156 | 8 | IPR002126 | |
| Domain | EGF-like_dom | CNTNAP3B HSPG2 FAT3 CNTNAP3 LAMA4 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 8.06e-06 | 249 | 156 | 11 | IPR000742 |
| Domain | EGF_1 | CNTNAP3B HSPG2 FAT3 CNTNAP3 LAMA4 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 1.01e-05 | 255 | 156 | 11 | PS00022 |
| Domain | GOLGA2L5 | 1.31e-05 | 18 | 156 | 4 | PF15070 | |
| Domain | Golgin_A | 1.31e-05 | 18 | 156 | 4 | IPR024858 | |
| Domain | EGF_3 | CNTNAP3B HSPG2 FAT3 CNTNAP3 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 2.90e-05 | 235 | 156 | 10 | PS50026 |
| Domain | Cadherin_CS | 3.62e-05 | 109 | 156 | 7 | IPR020894 | |
| Domain | EGF-like_CS | HSPG2 FAT3 CNTNAP3 LAMA4 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 7.01e-05 | 261 | 156 | 10 | IPR013032 |
| Domain | EGF_CA | 7.44e-05 | 122 | 156 | 7 | SM00179 | |
| Domain | EGF_2 | CNTNAP3B HSPG2 FAT3 CNTNAP3 SCUBE1 FAT2 NRXN3 SCUBE2 CELSR2 PROS1 | 7.96e-05 | 265 | 156 | 10 | PS01186 |
| Domain | EGF-like_Ca-bd_dom | 8.24e-05 | 124 | 156 | 7 | IPR001881 | |
| Domain | EGF | 9.12e-05 | 126 | 156 | 7 | PF00008 | |
| Domain | ASX_HYDROXYL | 1.93e-04 | 100 | 156 | 6 | PS00010 | |
| Domain | Cadherin_tail | 2.50e-04 | 37 | 156 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 2.50e-04 | 37 | 156 | 4 | IPR031904 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.64e-04 | 106 | 156 | 6 | IPR000152 | |
| Domain | Cadherin_C | 4.09e-04 | 42 | 156 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.09e-04 | 42 | 156 | 4 | PF16492 | |
| Domain | CUB | 7.41e-04 | 49 | 156 | 4 | PF00431 | |
| Domain | CUB | 8.00e-04 | 50 | 156 | 4 | SM00042 | |
| Domain | - | 9.28e-04 | 52 | 156 | 4 | 2.60.120.290 | |
| Domain | CUB | 9.98e-04 | 53 | 156 | 4 | PS01180 | |
| Domain | p53-like_TF_DNA-bd | 9.98e-04 | 53 | 156 | 4 | IPR008967 | |
| Domain | OSR1_C | 1.02e-03 | 6 | 156 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.02e-03 | 6 | 156 | 2 | IPR024678 | |
| Domain | PKD/REJ-like | 1.02e-03 | 6 | 156 | 2 | IPR002859 | |
| Domain | REJ | 1.02e-03 | 6 | 156 | 2 | PF02010 | |
| Domain | CUB_dom | 1.31e-03 | 57 | 156 | 4 | IPR000859 | |
| Domain | TMOD | 1.42e-03 | 7 | 156 | 2 | IPR004934 | |
| Domain | Tropomodulin | 1.42e-03 | 7 | 156 | 2 | PF03250 | |
| Domain | Nuc_translocat | 1.88e-03 | 8 | 156 | 2 | IPR001067 | |
| Domain | EGF_LAM_2 | 1.97e-03 | 30 | 156 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.97e-03 | 30 | 156 | 3 | PS01248 | |
| Domain | Cadherin_2 | 2.13e-03 | 65 | 156 | 4 | PF08266 | |
| Domain | Cadherin_N | 2.13e-03 | 65 | 156 | 4 | IPR013164 | |
| Pubmed | TLK2 DLGAP2 CACNA2D1 PDE4B WDR7 GOLGA6C GOLGA6D DAPK1 GOLGA6B GOLGA6A GRIN2B XRCC5 WDR47 CELSR2 KLHL7 KCNMA1 DLG2 TNS1 NOS1 WNK3 WNK2 SEC23A RAI1 | 8.91e-11 | 963 | 158 | 23 | 28671696 | |
| Pubmed | 7.62e-09 | 16 | 158 | 5 | 18166528 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | CACNA2D1 PDE4B WDR7 DAO REL CSMD2 ANKRD44 SLC24A2 CSMD1 R3HDM1 TNS1 | 4.09e-08 | 265 | 158 | 11 | 19240061 |
| Pubmed | 7.20e-08 | 24 | 158 | 5 | 21187406 | ||
| Pubmed | 8.96e-08 | 25 | 158 | 5 | 26143639 | ||
| Pubmed | 8.96e-08 | 25 | 158 | 5 | 29587143 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 25151305 | ||
| Pubmed | 1.11e-07 | 26 | 158 | 5 | 19474315 | ||
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 1.11e-07 | 26 | 158 | 5 | 31655624 | |
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 1.11e-07 | 26 | 158 | 5 | 32673396 | |
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 16380905 | ||
| Pubmed | 1.97e-07 | 29 | 158 | 5 | 31436800 | ||
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 2.84e-07 | 13 | 158 | 4 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 2.84e-07 | 13 | 158 | 4 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 2.84e-07 | 13 | 158 | 4 | 32873390 | |
| Pubmed | 2.84e-07 | 13 | 158 | 4 | 21552007 | ||
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 2.84e-07 | 13 | 158 | 4 | 28028212 | |
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 2.84e-07 | 13 | 158 | 4 | 29128360 | |
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 37831422 | ||
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 3.96e-07 | 14 | 158 | 4 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 3.96e-07 | 14 | 158 | 4 | 33543287 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 5.38e-07 | 15 | 158 | 4 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 5.38e-07 | 15 | 158 | 4 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 5.38e-07 | 15 | 158 | 4 | 17189423 | |
| Pubmed | 5.38e-07 | 15 | 158 | 4 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 5.38e-07 | 15 | 158 | 4 | 28509431 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 5.38e-07 | 15 | 158 | 4 | 26165940 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 5.38e-07 | 15 | 158 | 4 | 17204322 | |
| Pubmed | 5.38e-07 | 15 | 158 | 4 | 16413118 | ||
| Pubmed | 5.38e-07 | 15 | 158 | 4 | 26083584 | ||
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 7.04e-07 | 37 | 158 | 5 | 21725307 | |
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 16399995 | ||
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 7.15e-07 | 16 | 158 | 4 | 21640725 | |
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 16336229 | ||
| Pubmed | 9.32e-07 | 17 | 158 | 4 | 28717168 | ||
| Pubmed | 9.32e-07 | 17 | 158 | 4 | 27655914 | ||
| Pubmed | 9.32e-07 | 17 | 158 | 4 | 14728599 | ||
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 9.32e-07 | 17 | 158 | 4 | 14718562 | |
| Pubmed | 9.32e-07 | 17 | 158 | 4 | 20004763 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 9.75e-07 | 72 | 158 | 6 | 10380929 | |
| Pubmed | Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain. | 1.05e-06 | 40 | 158 | 5 | 26383973 | |
| Pubmed | 1.19e-06 | 41 | 158 | 5 | 30022023 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 15800058 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 1.19e-06 | 18 | 158 | 4 | 20230794 | |
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 25208654 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 21147753 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 24227724 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 22718342 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 20943658 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 1.19e-06 | 18 | 158 | 4 | 24367100 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.25e-06 | 171 | 158 | 8 | 20201926 | |
| Pubmed | 1.45e-06 | 77 | 158 | 6 | 10835267 | ||
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.51e-06 | 19 | 158 | 4 | 34042944 | |
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.51e-06 | 19 | 158 | 4 | 14622145 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.51e-06 | 19 | 158 | 4 | 38048369 | |
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 22841714 | ||
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 23444373 | ||
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 12646573 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.51e-06 | 19 | 158 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.51e-06 | 19 | 158 | 4 | 17664336 | |
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 17724343 | ||
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 1.51e-06 | 19 | 158 | 4 | 34255394 | |
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.51e-06 | 19 | 158 | 4 | 17003038 | |
| Pubmed | FLNB WASL SETMAR DCAF8 KIAA0319L POLR1C ADAMTS8 GRIN2B REV3L ANKRD6 SH2B1 RYR3 WDR47 SH3YL1 USP8 FBH1 KLHL7 PKD1 DLG2 R3HDM1 | 1.69e-06 | 1285 | 158 | 20 | 35914814 | |
| Pubmed | BCAS2 regulates oocyte meiotic prophase I by participating in mRNA alternative splicing. | 1.71e-06 | 44 | 158 | 5 | 38085152 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.82e-06 | 80 | 158 | 6 | 10716726 | |
| Pubmed | 1.88e-06 | 20 | 158 | 4 | 23918928 | ||
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 1.88e-06 | 20 | 158 | 4 | 21300694 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.88e-06 | 20 | 158 | 4 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 1.88e-06 | 20 | 158 | 4 | 34128978 | |
| Pubmed | 1.88e-06 | 20 | 158 | 4 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 1.88e-06 | 20 | 158 | 4 | 29437892 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 1.88e-06 | 20 | 158 | 4 | 20368623 | |
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.88e-06 | 20 | 158 | 4 | 31949138 | |
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 2.31e-06 | 21 | 158 | 4 | 27118846 | |
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 21645620 | ||
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 36292593 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 2.31e-06 | 21 | 158 | 4 | 19061864 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 2.31e-06 | 21 | 158 | 4 | 22216013 | |
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 23386608 | ||
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 15229288 | ||
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 2.31e-06 | 21 | 158 | 4 | 20003423 | |
| Pubmed | 2.81e-06 | 22 | 158 | 4 | 34897463 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 2.81e-06 | 22 | 158 | 4 | 36656123 | |
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 3.26e-06 | 50 | 158 | 5 | 24191021 | |
| Pubmed | 3.39e-06 | 23 | 158 | 4 | 25636444 | ||
| Pubmed | 3.39e-06 | 23 | 158 | 4 | 18662990 | ||
| Pubmed | 3.39e-06 | 23 | 158 | 4 | 37848288 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 3.39e-06 | 23 | 158 | 4 | 21111240 | |
| Pubmed | 3.39e-06 | 23 | 158 | 4 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 3.39e-06 | 23 | 158 | 4 | 18547789 | |
| Pubmed | 4.06e-06 | 24 | 158 | 4 | 26060116 | ||
| Pubmed | 4.06e-06 | 24 | 158 | 4 | 24161848 | ||
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 4.06e-06 | 24 | 158 | 4 | 22364862 | |
| Pubmed | 4.06e-06 | 24 | 158 | 4 | 38814743 | ||
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 4.06e-06 | 24 | 158 | 4 | 18434600 | |
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 4.06e-06 | 24 | 158 | 4 | 20223754 | |
| Interaction | CD160 interactions | 1.77e-06 | 48 | 155 | 6 | int:CD160 | |
| Interaction | CLRN3 interactions | 2.28e-06 | 13 | 155 | 4 | int:CLRN3 | |
| Cytoband | 5q31 | 5.13e-05 | 115 | 158 | 5 | 5q31 | |
| GeneFamily | Cadherin related | 1.25e-04 | 17 | 106 | 3 | 24 | |
| GeneFamily | Tropomodulins | 2.03e-04 | 4 | 106 | 2 | 1140 | |
| GeneFamily | Clustered protocadherins | 5.41e-04 | 64 | 106 | 4 | 20 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.01e-04 | 7 | 106 | 2 | 1350 | |
| GeneFamily | Gla domain containing | 2.55e-03 | 13 | 106 | 2 | 1250 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | BOC NXPH1 GRID1 ITGAV MAP3K1 ANKRD44 SCUBE2 TMOD1 BAMBI DSEL TNS1 PCDHGC3 | 2.43e-06 | 366 | 158 | 12 | M39052 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.66e-05 | 143 | 158 | 7 | M1935 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.66e-05 | 143 | 158 | 7 | MM819 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 2.92e-05 | 199 | 158 | 8 | M4886 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NXPH1 GRID1 REV3L RFX7 CSMD2 ANKRD44 FAT2 NRXN3 SLC24A2 KLHL13 CAPRIN2 KCNMA1 DLG2 CSMD1 R3HDM1 WNK3 ADGRD1 RAI1 SCN3B | 4.00e-05 | 1106 | 158 | 19 | M39071 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 4.02e-05 | 337 | 158 | 10 | M13206 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | CACNA2D1 PDE4B MGAT4A LAMA4 ADAMTS8 REV3L ADCY5 MYORG RYR3 POSTN SCUBE2 KCNMA1 TIFA TBX20 TNS1 VASP ADGRD1 SCN3B | 1.07e-05 | 761 | 154 | 18 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_200 | 2.24e-05 | 160 | 154 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | DOCK2 BOC CACNA2D1 FAT3 ABHD3 DAPK1 REV3L ME2 POSTN SCUBE1 ARNT HOXC4 KLHL13 CAPRIN2 KYAT3 DSEL WNK3 | 2.77e-05 | 740 | 154 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#2_top-relative-expression-ranked_500 | 2.92e-05 | 166 | 154 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.67e-05 | 89 | 154 | 6 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | CACNA2D1 PDE4B MYOT MGAT4A PAQR5 LAMA4 REV3L ADCY5 RYR3 NEDD9 POSTN SCUBE2 KCNMA1 TBX20 TNS1 ADGRD1 SCN3B | 4.70e-05 | 772 | 154 | 17 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 8.72e-05 | 62 | 154 | 5 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.09e-04 | 65 | 154 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 1.18e-04 | 105 | 154 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | TLK2 CACNA2D1 WASL FAT3 NXPH1 REV3L ANKRD6 CPED1 ME2 MYORG HOXC4 | 1.71e-04 | 401 | 154 | 11 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A2 PLB1 WDR64 FAT3 LRTM1 MUC5B GRIN2B GALNT13 RYR3 KCNMA1 TIFA | 1.39e-11 | 160 | 158 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A2 PLB1 WDR64 FAT3 LRTM1 MUC5B GRIN2B GALNT13 RYR3 KCNMA1 TIFA | 1.39e-11 | 160 | 158 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL5A2 MXRA5 ATP8A2 LAMA4 GRID1 REV3L CSMD2 CPED1 POSTN SCUBE1 SCUBE2 | 7.97e-11 | 188 | 158 | 11 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | DOCK2 CNTNAP3B CNTNAP3 LAMA4 GRIN2B ITGA2 GALNT13 NEDD9 NRXN3 BAMBI | 1.09e-09 | 182 | 158 | 10 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-08 | 178 | 158 | 9 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.73e-08 | 180 | 158 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-08 | 198 | 158 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.33e-08 | 149 | 158 | 8 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-07 | 174 | 158 | 8 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.09e-07 | 174 | 158 | 8 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-07 | 174 | 158 | 8 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-07 | 174 | 158 | 8 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.60e-07 | 179 | 158 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-07 | 181 | 158 | 8 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-07 | 181 | 158 | 8 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-07 | 185 | 158 | 8 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 3.93e-07 | 189 | 158 | 8 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 3.93e-07 | 189 | 158 | 8 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 3.93e-07 | 189 | 158 | 8 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-07 | 191 | 158 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.43e-07 | 192 | 158 | 8 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 192 | 158 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 192 | 158 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.61e-07 | 193 | 158 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-07 | 196 | 158 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-07 | 196 | 158 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-07 | 196 | 158 | 8 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.38e-07 | 197 | 158 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-07 | 197 | 158 | 8 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-07 | 198 | 158 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-07 | 198 | 158 | 8 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-07 | 198 | 158 | 8 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-07 | 199 | 158 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-07 | 199 | 158 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.03e-07 | 200 | 158 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.03e-07 | 200 | 158 | 8 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.03e-07 | 200 | 158 | 8 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-06 | 155 | 158 | 7 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-06 | 100 | 158 | 6 | 2e1c6fa2b48a6e3367b76b79dec58aea9c4662e0 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 164 | 158 | 7 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 164 | 158 | 7 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 170 | 158 | 7 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 170 | 158 | 7 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 170 | 158 | 7 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.67e-06 | 171 | 158 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-06 | 173 | 158 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.88e-06 | 173 | 158 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-06 | 175 | 158 | 7 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-06 | 175 | 158 | 7 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-06 | 176 | 158 | 7 | 91ad2c34144f72283ca112fd3b3784f2f6259f65 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 180 | 158 | 7 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 180 | 158 | 7 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-06 | 182 | 158 | 7 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-06 | 182 | 158 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.17e-06 | 183 | 158 | 7 | 5ac38a2ce93c53f23a89faf287b81ea138560623 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.64e-06 | 186 | 158 | 7 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.98e-06 | 188 | 158 | 7 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.98e-06 | 188 | 158 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 189 | 158 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-06 | 189 | 158 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 189 | 158 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-06 | 189 | 158 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.16e-06 | 189 | 158 | 7 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 5.16e-06 | 189 | 158 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.16e-06 | 189 | 158 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-06 | 189 | 158 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.34e-06 | 190 | 158 | 7 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.34e-06 | 190 | 158 | 7 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.34e-06 | 190 | 158 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-06 | 190 | 158 | 7 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-06 | 190 | 158 | 7 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.34e-06 | 190 | 158 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.53e-06 | 191 | 158 | 7 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-06 | 191 | 158 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 192 | 158 | 7 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.72e-06 | 192 | 158 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-06 | 193 | 158 | 7 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.92e-06 | 193 | 158 | 7 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.92e-06 | 193 | 158 | 7 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.92e-06 | 193 | 158 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.92e-06 | 193 | 158 | 7 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.12e-06 | 194 | 158 | 7 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.33e-06 | 195 | 158 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.33e-06 | 195 | 158 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-06 | 195 | 158 | 7 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-06 | 195 | 158 | 7 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 196 | 158 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.55e-06 | 196 | 158 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.77e-06 | 197 | 158 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 197 | 158 | 7 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-06 | 197 | 158 | 7 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.77e-06 | 197 | 158 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A | PDE4B KIAA0319L LAMA4 ECE1 NEDD9 ARNT R3HDM1 USF2 TNS1 UTY IL17RB | 1.23e-07 | 200 | 154 | 11 | 4076_DN |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | COL5A2 HSPG2 HDAC5 KIAA0319L ECE1 NEDD9 PLA2G6 NOS1 UTY PGBD5 | 9.31e-07 | 196 | 154 | 10 | 4366_DN |
| Disease | cortical thickness | COL5A2 HSPG2 FLNB VRK2 DCDC1 FAT3 ESPNL POLR1C ADAMTS8 ECE1 CPED1 CLOCK ME2 MAP3K1 NHSL1 SEPSECS SCUBE1 PKD1 TNS1 WNK2 | 1.11e-06 | 1113 | 151 | 20 | EFO_0004840 |
| Disease | Schizophrenia | DLGAP2 VRK2 PDE4B MYO9B DAO GRID1 GRIN2B CSMD2 CLOCK ME2 NRXN3 DLG2 PLA2G6 CSMD1 NOS1 WNK3 RAI1 | 3.04e-06 | 883 | 151 | 17 | C0036341 |
| Disease | waist-hip ratio | VRK2 MYO9B LAMA4 GRIN2B RFX7 ANKRD6 ECE1 CPED1 CLOCK BIRC6 ADCY5 SH2B1 NEDD9 HOXC4 NRXN3 SCUBE2 CAPRIN2 PKD1 DLG2 | 1.72e-05 | 1226 | 151 | 19 | EFO_0004343 |
| Disease | coronary aneurysm | 3.05e-05 | 35 | 151 | 4 | EFO_1000881 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.26e-05 | 71 | 151 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | amino acid measurement | MOXD2P DLGAP2 CACNA2D1 DCDC1 NXPH1 CNTNAP3 GRIN2B ITGA2 RYR3 KCNMA1 DLG2 CSMD1 WNK2 | 4.89e-05 | 678 | 151 | 13 | EFO_0005134 |
| Disease | alcohol sensitivity | 7.78e-05 | 3 | 151 | 2 | C0678306 | |
| Disease | electrodermal activity measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0006866 | |
| Disease | colorectal health | 8.27e-05 | 201 | 151 | 7 | EFO_0008460 | |
| Disease | severe acute respiratory syndrome, COVID-19 | DLGAP2 CACNA2D1 MXRA5 ATP8A2 DCAF8L2 LRTM1 SEPSECS SCUBE1 KCNMA1 CSMD1 | 1.08e-04 | 447 | 151 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Depressive disorder | 1.27e-04 | 289 | 151 | 8 | C0011581 | |
| Disease | cardiovascular disease | 1.29e-04 | 457 | 151 | 10 | EFO_0000319 | |
| Disease | brain measurement, neuroimaging measurement | COL5A2 VRK2 DCDC1 FAT3 ADAMTS8 CPED1 MAP3K1 NHSL1 DLG2 TNS1 WNK2 | 1.31e-04 | 550 | 151 | 11 | EFO_0004346, EFO_0004464 |
| Disease | hypertension (biomarker_via_orthology) | 1.76e-04 | 227 | 151 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | 1.83e-04 | 477 | 151 | 10 | C0005586 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.57e-04 | 60 | 151 | 4 | C4722327 | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 2.58e-04 | 5 | 151 | 2 | DOID:11723 (is_marker_for) | |
| Disease | estrogen measurement, response to aromatase inhibitor | 2.58e-04 | 5 | 151 | 2 | EFO_0011007, GO_0061477 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 2.74e-04 | 61 | 151 | 4 | DOID:3021 (biomarker_via_orthology) | |
| Disease | neuroblastoma | 3.34e-04 | 116 | 151 | 5 | EFO_0000621 | |
| Disease | Mental Depression | 3.47e-04 | 254 | 151 | 7 | C0011570 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.85e-04 | 6 | 151 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Barrett's esophagus | 3.92e-04 | 28 | 151 | 3 | EFO_0000280 | |
| Disease | neuroimaging measurement | COL5A2 VRK2 DCDC1 FAT3 NXPH1 REV3L MAP3K1 NHSL1 PKD1 DLG2 UROS TMC5 TNS1 WNK2 RAI1 | 4.03e-04 | 1069 | 151 | 15 | EFO_0004346 |
| Disease | coronary artery disease | MYO9B TMOD4 ANKRD6 CLOCK GALNT13 MAP3K1 EPG5 NEDD9 SCUBE1 CELSR2 CYP2G1P GPR149 TBX20 TNS1 WNK2 RAI1 | 4.27e-04 | 1194 | 151 | 16 | EFO_0001645 |
| Disease | Prostate cancer, familial | 4.40e-04 | 69 | 151 | 4 | C2931456 | |
| Disease | nucleotide measurement | 5.45e-04 | 73 | 151 | 4 | EFO_0010513 | |
| Disease | cortical surface area measurement | COL5A2 FLNB CACNA2D1 VRK2 DCDC1 MYO9B ATP8A2 FAT3 DAPK1 CPED1 MAP3K1 NHSL1 SEPSECS SCUBE1 PKD1 TNS1 WNK2 | 5.46e-04 | 1345 | 151 | 17 | EFO_0010736 |
| Disease | neuropsychological test | 5.48e-04 | 197 | 151 | 6 | EFO_0003926 | |
| Disease | Cardiomyopathies | 5.62e-04 | 130 | 151 | 5 | C0878544 | |
| Disease | respiratory symptom measurement, COVID-19 | 5.74e-04 | 74 | 151 | 4 | EFO_0007939, MONDO_0100096 | |
| Disease | eating disorder | 5.84e-04 | 32 | 151 | 3 | EFO_0005203 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.03e-04 | 132 | 151 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 6.04e-04 | 75 | 151 | 4 | EFO_0007006, EFO_0009262 | |
| Disease | colorectal adenoma | 6.40e-04 | 33 | 151 | 3 | EFO_0005406 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 7.14e-04 | 8 | 151 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | attempted suicide, mood disorder | 7.14e-04 | 8 | 151 | 2 | EFO_0004247, EFO_0004321 | |
| Disease | carbonic anhydrase-related protein 10 measurement | 7.14e-04 | 8 | 151 | 2 | EFO_0020233 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 7.14e-04 | 8 | 151 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | rectum cancer (is_implicated_in) | 9.15e-04 | 9 | 151 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | Allodynia | 9.25e-04 | 84 | 151 | 4 | C0458247 | |
| Disease | Mechanical Allodynia | 9.25e-04 | 84 | 151 | 4 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 9.25e-04 | 84 | 151 | 4 | C0751212 | |
| Disease | Hyperalgesia, Primary | 9.25e-04 | 84 | 151 | 4 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 9.25e-04 | 84 | 151 | 4 | C0751214 | |
| Disease | Tactile Allodynia | 9.25e-04 | 84 | 151 | 4 | C0751213 | |
| Disease | Hyperalgesia | 9.25e-04 | 84 | 151 | 4 | C0020429 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.05e-03 | 39 | 151 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | brain connectivity measurement | 1.10e-03 | 400 | 151 | 8 | EFO_0005210 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.14e-03 | 10 | 151 | 2 | GO_0097327, GO_0097328 | |
| Disease | urate measurement, bone density | 1.37e-03 | 619 | 151 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | Other specified cardiac arrhythmias | 1.39e-03 | 11 | 151 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 1.39e-03 | 11 | 151 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 1.39e-03 | 11 | 151 | 2 | C1399226 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.39e-03 | 11 | 151 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 1.39e-03 | 11 | 151 | 2 | C2748542 | |
| Disease | Bipolar I disorder | 1.39e-03 | 11 | 151 | 2 | C0853193 | |
| Disease | survival time, lung adenocarcinoma | 1.66e-03 | 12 | 151 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | Abruptio Placentae | 1.66e-03 | 12 | 151 | 2 | EFO_1001754 | |
| Disease | Neurobehavioral Manifestations | 1.66e-03 | 12 | 151 | 2 | C0525041 | |
| Disease | corpus callosum volume measurement | 1.77e-03 | 100 | 151 | 4 | EFO_0010299 | |
| Disease | neurotic disorder | 1.83e-03 | 101 | 151 | 4 | EFO_0004257 | |
| Disease | hyperglycemia (is_marker_for) | 1.96e-03 | 13 | 151 | 2 | DOID:4195 (is_marker_for) | |
| Disease | illegal drug consumption | 1.96e-03 | 13 | 151 | 2 | EFO_0005431 | |
| Disease | Brugada Syndrome 1 | 1.96e-03 | 13 | 151 | 2 | C4551804 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.96e-03 | 13 | 151 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | blood phosphate measurement | 2.06e-03 | 174 | 151 | 5 | EFO_0010972 | |
| Disease | Unipolar Depression | 2.23e-03 | 259 | 151 | 6 | C0041696 | |
| Disease | grip strength measurement | 2.24e-03 | 350 | 151 | 7 | EFO_0006941 | |
| Disease | Autistic Disorder | 2.32e-03 | 261 | 151 | 6 | C0004352 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 2.50e-03 | 110 | 151 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.55e-03 | 53 | 151 | 3 | C4707243 | |
| Disease | quinate measurement | 2.61e-03 | 15 | 151 | 2 | EFO_0021167 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.61e-03 | 15 | 151 | 2 | C0428908 | |
| Disease | Alcoholic Intoxication, Chronic | 2.64e-03 | 268 | 151 | 6 | C0001973 | |
| Disease | Hypermetropia, Myopia | 2.94e-03 | 189 | 151 | 5 | HP_0000540, HP_0000545 | |
| Disease | Schizoaffective disorder-bipolar type | 2.98e-03 | 16 | 151 | 2 | EFO_0009965 | |
| Disease | optic cup area measurement | 2.99e-03 | 56 | 151 | 3 | EFO_0006940 | |
| Disease | phosphatidylcholine 40:6 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010389 | |
| Disease | banks of the superior temporal sulcus volume measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010286 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.36e-03 | 17 | 151 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | neuroimaging measurement, brain volume measurement | 3.63e-03 | 286 | 151 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | fasting blood glucose measurement | 3.69e-03 | 287 | 151 | 6 | EFO_0004465 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.20e-03 | 19 | 151 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | anorectal malformation | 4.20e-03 | 19 | 151 | 2 | MONDO_0019938 | |
| Disease | mean arterial pressure | 4.29e-03 | 499 | 151 | 8 | EFO_0006340 | |
| Disease | tea consumption measurement | 4.42e-03 | 129 | 151 | 4 | EFO_0010091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDGLASYNHSQVVQP | 516 | P27540 | |
| SHQIVPGGRYGVQSF | 461 | O95936 | |
| YVSHNQGSGLAQQPY | 661 | Q9HCE0 | |
| QGCFVDYQDRHGNTP | 566 | P53355 | |
| GFPGNTNADSVVHYR | 131 | Q9BZ76 | |
| ETTGGHSVRFNPNLY | 4646 | Q9NR09 | |
| IRHGQQNFPESFEYG | 2806 | Q96PZ7 | |
| TPHFGIQNSSRGYEV | 3221 | Q96PZ7 | |
| DGNHRQRGFSAQYQV | 291 | Q7Z408 | |
| GIPVNGQRHGNDFYV | 871 | Q7Z408 | |
| PIVNGHINGENYSYR | 2721 | Q7Z408 | |
| PFNGYAGHENTNVRA | 3441 | Q7Z408 | |
| SYQNQGIYQVPTGHG | 111 | Q14511 | |
| QGTVTNFRSPYHVRG | 991 | A4D0V7 | |
| FQVRGVYSRSQDHPG | 21 | Q6QNK2 | |
| RSHPGVQNDGNYLAL | 721 | Q9UP79 | |
| ATEAQPQGHLQRYST | 166 | Q7RTS1 | |
| QNPNVALVLTSYGGH | 361 | Q8WU67 | |
| GQRPLGEHQTQTYLQ | 471 | Q9P1A6 | |
| PSEHGSQQSIFNRYA | 496 | Q6MZZ7 | |
| GPGHAILSFDYGQQR | 1711 | Q9HCU4 | |
| SASQYGQDTIRGHPG | 3101 | P20930 | |
| NRTGSRGFVDYPNHQ | 2606 | Q96M86 | |
| AERPFYNHLGGNQVS | 676 | O95622 | |
| EGNEPGETTQITYHQ | 126 | Q9NR19 | |
| LHRVVPHGQSFQNGY | 131 | P07384 | |
| EGPNRHLYDFTGNLN | 241 | Q9NTI2 | |
| FRGSSLQQGVPHGYA | 1146 | Q9NTI2 | |
| LQQGVPHGYAFSQEE | 1151 | Q9NTI2 | |
| VNNAGQTPLETARYH | 236 | Q9Y2G4 | |
| ARLPYSLFHNNTEGQ | 5206 | Q9HC84 | |
| SSVGYLQHPGSEQVQ | 786 | Q15032 | |
| DRPGHVSQKYSQEGN | 381 | Q8IXT5 | |
| QYAEQGAQVPFRTHS | 156 | Q7Z5J4 | |
| QQRLSGSHSQGVAYP | 2521 | P98160 | |
| VYESQGAVPNTRHQE | 571 | Q9NYA3 | |
| VAHPGIQGNLNSYYS | 171 | P10746 | |
| NDNAPVFGQSAYLVH | 446 | Q9Y5F8 | |
| GLSARYGPQFTLQHV | 871 | Q9Y5F8 | |
| LRTGPSNTEVIHNYG | 296 | P14920 | |
| EQGILFGYRHPQSSA | 21 | Q9NXK6 | |
| PVNVESYLFHSGNQE | 436 | Q9UM21 | |
| DYLQSQFGPNRLVHS | 71 | M0R2J8 | |
| RYSQTHQAILGPFGE | 486 | Q6ZVH7 | |
| ITAQYHGGPLAQTND | 316 | Q9HBL6 | |
| PYSSQDVFGNLQREH | 26 | Q9P2W1 | |
| TQVEFYQGSVLNPHD | 461 | Q12791 | |
| FGHRQNSTGIPYSRI | 521 | O95528 | |
| QNAHGEGYVNVTVKP | 386 | Q8IZA0 | |
| GSREYVNVSQELHPG | 216 | O43561 | |
| NVSTGRLAFGNHYQP | 206 | Q2LD37 | |
| GYYQNVNGVHASEPV | 361 | Q6ZUT3 | |
| NTVYFIGAHNIPNAN | 131 | Q9NRM6 | |
| VGGYEENHTNQPFFI | 616 | Q8N448 | |
| HRNNTTVKGVNFYGP | 466 | P0C7V8 | |
| GTFLYQRGHPQADEN | 356 | Q5SYE7 | |
| YRGQHVTGSPFQFTV | 2171 | O75369 | |
| QGLPRGHYSFNVTVS | 3591 | Q9NYQ8 | |
| GLSARYGPQFTLQHV | 886 | Q9Y5F6 | |
| NIFNVAGYSHNRPLT | 351 | Q07343 | |
| TIYVNPANTHQFAVG | 336 | Q5TAQ9 | |
| HRNNATVKGVNFYGP | 431 | Q5TAQ9 | |
| EHYPTGRQLTIFNTQ | 1201 | Q9Y4C0 | |
| QQVASGRAGVFTQYH | 76 | Q6B0I6 | |
| RQYVRSVAPGFQHVG | 371 | Q6W3E5 | |
| HDYRIALFGGSQPQS | 291 | Q8IXQ5 | |
| GYTPLHAAASNGQIN | 206 | Q8N8A2 | |
| GLSARYGPQFTLQHV | 871 | Q9Y5G1 | |
| GLSARYGPQFTLQHV | 876 | Q9UN70 | |
| VYESQGAVPNTRHQE | 571 | A6NDN3 | |
| HFVAGAPRANYTGQI | 451 | P17301 | |
| HVAAGTQQPYTDGVR | 541 | P14923 | |
| GQSHRSRNIGSNYPE | 886 | Q7Z6E9 | |
| RLHTNGSQELQYQPG | 1021 | P29475 | |
| QAFIHNSLYGPGTNR | 191 | Q9UMY1 | |
| YTFPGGTGHVINKNN | 351 | Q8IUC8 | |
| HSNYQEISRGASIPG | 226 | Q86SP6 | |
| HFRFLTNAYSPVQQG | 411 | Q8N414 | |
| GDPHQQIYTFRGAVN | 671 | Q8NFZ0 | |
| DAPRYQHGIAVIGNF | 376 | Q9P2N7 | |
| RQTHLGNGYDPQSHQ | 971 | Q9BWV1 | |
| RHGVAIYNFQGSGAP | 11 | Q92608 | |
| PRGEASGQGNRYQHD | 116 | Q13145 | |
| TFSVGQHNYDRGPIQ | 386 | P54289 | |
| SFRYSIGPGNVNNHF | 601 | Q6ZTQ4 | |
| GAANDGRIYKHSQQP | 331 | Q6ZNA5 | |
| VQHIYELRNNGPSSF | 806 | P06756 | |
| DYGHFEINPNSGNVI | 2126 | Q8TDW7 | |
| VNRQVSYHITGGNPR | 2956 | Q8TDW7 | |
| KIHVSTVNPNYNGGE | 141 | P09017 | |
| VYESQGAVPNTRHQE | 571 | A6NDK9 | |
| QFAYGDHQSPNTAIT | 1371 | P05997 | |
| TAANYHPDGTIQVSN | 821 | Q6IMN6 | |
| DGRVFTPGQGNNVYI | 456 | P23368 | |
| VYESQGAVPNTRHQE | 571 | P0CG33 | |
| QAPDGRYGHQLHNTS | 486 | Q9ULK0 | |
| VGNQHIPGDNSIYVT | 211 | Q15700 | |
| PRGNSELLYHNQTVF | 126 | Q9H293 | |
| NYSVNGEPVNGRHTL | 651 | P42892 | |
| IHHGNGTQQAFYNDP | 871 | Q9UQL6 | |
| VGTYQPEFGQNHCIT | 761 | Q8IWY4 | |
| NEGNSARGFQVPYVT | 906 | Q9NQ36 | |
| PGFQRTVGIADSNYN | 321 | Q8IZU8 | |
| IDSLNQYTRGFGHPS | 91 | Q6YP21 | |
| GFPGNTNADSVVHYR | 131 | Q96NU0 | |
| QVVGGGRYFPTNHTV | 1636 | P98161 | |
| GRYFPTNHTVQLQAV | 1641 | P98161 | |
| QYGGTANSRQEFEHL | 1471 | Q16363 | |
| GVLPNGNVYFSDQHL | 86 | A6NHM9 | |
| ESNFNLTHYGTQQIP | 536 | Q13233 | |
| SYNFHTGLDQQGFIP | 776 | Q8ND04 | |
| VDLGTVYNQPGHQFC | 166 | Q2WGJ9 | |
| EQPLFSTGSAQYHQA | 606 | O14607 | |
| EEGGHPRAINNQYSF | 741 | Q9NRF2 | |
| YHPGQLQCGIFQSIS | 21 | Q96CG3 | |
| SVVSGPRVAQGYHQR | 71 | Q9UI40 | |
| VYFRHNSTGQGNVSV | 151 | P58417 | |
| EHYPTGRQLTIFNTQ | 196 | Q9HDB5 | |
| GLSSYHERVGNLNQP | 271 | Q96HL8 | |
| EQQRLAGAQHPYAQG | 401 | Q68DV7 | |
| DPTYIGNIGRFLNHS | 211 | Q53H47 | |
| NGSRQGPNIDAHDYV | 161 | Q9UJ37 | |
| GETVFHYAVQGDNSQ | 186 | O60733 | |
| VRNVHTTDFPGNYSG | 21 | O15160 | |
| SNTHYRIPQGFGNLL | 6 | Q15506 | |
| DLVHYSPQNFTDNIG | 521 | Q6P1J6 | |
| PGSGIAQFHIDYNNV | 486 | P07225 | |
| RGAIQFVTQYQHSSG | 476 | Q15436 | |
| YGRKPFGHNQSQQDI | 676 | Q86UE8 | |
| GVPHNIIQDTQFRGY | 21 | Q6ZSU1 | |
| NGFEGTIQRTHRPSY | 231 | O15516 | |
| ANFHYPGVQNLSRSL | 346 | O94967 | |
| GKNRVQNPYSHGNIV | 266 | Q9Y397 | |
| SHLAFAETVQQYGPQ | 151 | A6NFC5 | |
| PEHNYNFDINTIGQT | 1641 | O60673 | |
| GYHFTQQGPRLRASN | 316 | P28289 | |
| QNDSQHRRIFYEAGG | 241 | Q15413 | |
| ATQAYGHEIPLRNGT | 1051 | Q9HBL0 | |
| EYRNGHQEVESPFQG | 76 | Q9NY72 | |
| HAFAVPGQSYQSQSR | 1001 | Q2KHR2 | |
| PNSHGFVQDSQYSGI | 586 | Q04864 | |
| DHNIQYQFRTETNGG | 61 | Q15853 | |
| SRFEGRQGHQEGYIN | 126 | Q9Y6R6 | |
| SIVRFGYHFTQQGPR | 311 | Q9NZQ9 | |
| GYHFTQQGPRARAAQ | 316 | Q9NZQ9 | |
| SRQYQTAIIIGPDGH | 406 | P17010 | |
| DIPHIVNNAYGVQSS | 246 | Q9HD40 | |
| QQGPYAAIQGLRHSS | 426 | Q9UMR3 | |
| FRNNFINPHIYSGGI | 551 | Q6UXY8 | |
| GLFQHQTTYNRVSPC | 181 | Q9HCX3 | |
| TNRFYGPQVNNISHT | 171 | O00401 | |
| LQVQVTYHAQAGQPG | 571 | Q9Y3S1 | |
| NLGLFINHYPNGVVT | 191 | Q15063 | |
| YSQPDRQGQSSHYGQ | 331 | Q6XPR3 | |
| DRQGQSSHYGQPDRQ | 431 | Q6XPR3 | |
| RQGQSFHYGQPDRQG | 516 | Q6XPR3 | |
| SNPQAHVSGVRFLYQ | 511 | Q6NUS6 | |
| TVTHFIYQGRPNDTN | 941 | Q92547 | |
| HTGIQFYQFSVGNQR | 111 | Q9Y4E6 | |
| PFNATGVTHYVQGNS | 221 | Q05996 | |
| QQQDYFHSILGPGNI | 81 | P40818 | |
| QYQENPRKGHNGTIE | 201 | Q86Y07 | |
| NPLSGGDQYQNITVH | 66 | P13010 | |
| HFTYNSCPEGARQQV | 246 | Q15386 | |
| TGLQVYQILEPHGFN | 486 | B1ANS9 | |
| AGTGPQAFSRVQIYH | 26 | P50552 | |
| GGITGNRQLTHQQIY | 731 | Q9C0D4 | |
| PGQIYSSQQLVGHYQ | 611 | Q9BYP7 | |
| GTDLQSGQQLQRFYH | 2581 | Q9NR99 | |
| NGHVFASYQVSIPQS | 1631 | Q13459 | |
| VHPFVNYNSSRFGEG | 391 | Q6NSJ0 | |
| HAGSNPGQRVTTTYN | 76 | Q9UBF9 | |
| NPRAFNGSSNGHVYE | 1461 | Q13224 |